-+ 0.00%
-+ 0.00%
-+ 0.00%

AMPLIA ENTERS INTO SECOND AGREEMENT WITH KOREAN SPECIALIST DRUG SCREENING COMPANY NEXT&BIO TO EXPLORE COMBINATION THERAPY WITH FAK INHIBITOR AND KRAS INHIBITORS

Reuters·12/19/2025 13:45:00

Please log in to view news